Search Results

Professional Development

ASHP Testimony on Compounding

ASHP Testimony during a hearing of the Health Subcommittee of the House of Representatives Energy and Commerce Committee on Reforming the Drug Compounding Regulatory Framework. Kasey Thompson testifies Date: 07/16/2013 Duration: 00:07:03 min

Advocacy and Issues

ASHP Urges FDA to Change Draft Compounding Guidances

[Submitted electronically to www.regulations.gov] Division of Dockets Management (HFA-305) U.S. Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Draft Compounding Guidances – Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Hos

Advocacy and Issues

Compounding

Legislative Advocacy ASHP Statement for the Record: "Examining Implementation of the Compounding Quality Act" Drug Quality and Security Act: Section 503A of the Food Drug & Cosmetic Act [PDF] Drug Quality and Security Act: Section 503B of the Food, Drug, & Cosmetic Act [PDF] A

Advocacy and Issues

Recent Legislative Activity on Opioids, Compounding

On May 16, 2018, the House Ways and Means Committee held a markup on eight bills related to opioid abuse, specifically among the Medicare population. Included in these bills are provisions from dozens of other opioid-related bills referred to the Committee. It is not clear at this point if and when

Advocacy and Issues

ASHP Submits Comments to the Kansas Board of Pharmacy on the Proposed Rules on Sterile and Non-Sterile Compounding

Ms. Alexandra Blasi, J.D., M.B.A. Executive Secretary Kansas State Board of Pharmacy 800 S.W. Jackson Suite 1414 Topeka, Kan. 66612-124 Subject: Letter Regarding the Proposed Rules on Sterile and Non-sterile Compounding (KAR 68-13-2, 68-13-3, 68-13-4) Dear Ms. Blasi: On behalf of the Kansas member

Compounding Sterile Preparations

Aseptic Technique and Sterile Compounding Procedures: Focus on the Basics Angela T. Cassano, Pharm.D., BCPS, FASHP President, Pharmfusion Consulting, LLC Midlothian, Virginia ACPE activity #0204-0000-13-421-H04-T 1 hour (0.1 CEU) Aseptic technique is critical to patient safety and all personnel invo

Sterile Compounding Coordinator

Site Name: Via Christi Hospitals Wichita, Inc. Primary Intended Outcome(s): and who has a four-year University degree. Remove pharmacists from routine IV room processes and procedures, as well as annual testing and employee training, so as to redirect their time to clin

ASHP Sterile Compounding Competency Library

The ASHP Sterile Compounding Competency Library moves ASHP's suite of best-selling Chapter <797> DVD training programs online, ensuring updates as requirements change.  The current catalog includes three full-length courses covering all sterile compounding practice requirements set forth in USP

Advocacy and Issues

FDA Issues Three Guidances on Pharmacy Compounding

[Submitted electronically to www.regulations.gov] Division of Dockets Management (HFA-305) U.S. Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Draft Compounding Guidances – Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Hos

Advocacy and Issues

Statement: "Examining Implementation of the Compounding Quality Act"

ASHP (American Society of Health-System Pharmacists) is pleased to offer the following statement for the record on pharmaceutical compounding. ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s 45,000 members include pharmacists, stud